BetterLife Pharma Inc.
BETR.CN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$35.71M
Close$
$-0.01
102.8% downside
Current Fair Value
102.8% downsideOvervalued by 102.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $35.71 Million |
|---|---|
| Enterprise Value | $37.25 Million |
| Earnings per Share | $-0.01 |
| Beta | 0.22 |
| Outstanding Shares | 162,322,501 |
Return
| Return on Equity | 32.03% |
|---|---|
| Return on Assets | -171.28% |
| Return on Invested Capital | 33.75% |
Valuation & Multiples
| P/E Ratio | -11.36 |
|---|---|
| PEG | -3.48 |
| Price to Sales | - |
| Price to Book Ratio | -0.22 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -14.46 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | -0.23 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BetterLife Pharma Inc.
4 employees
CEO: Ahmad Doroudian
BetterLife Pharma Inc. is a biotechnology company focused on the global development and commercialization of therapeutic compounds, particularly for neurological disorders. The firm also innovates drug candidates utilizing complementary ...